Literature DB >> 2194823

Inhibition of feeding by ACTH-(1-24): behavioral and pharmacological aspects.

A V Vergoni1, R Poggioli, D Marrama, A Bertolini.   

Abstract

The time course of the behavior of rats fasted for 24 h was analyzed with observation starting either 10 or 60 min after the i.c.v. administration of ACTH-(1-24) (4 micrograms/animal). The anorectic effect of this peptide was direct and specific because it could be dissociated in time from the grooming-inducing effect. The effect is a central one, not linked either to an interaction with the peripheral feeding-regulatory system, or to the release of adrenal steroids. ACTH-(1-24), like corticotropin-releasing factor (CRF), is capable of antagonizing the stimulation of feeding seen during starvation, insulin (10 IU/kg s.c.)-induced hypoglycemia, stimulation of GABAergic (muscimol, 250 ng/rat i.c.v.), noradrenergic (norepinephrine, 20 micrograms/rat i.c.v.) or opioidergic systems. The data suggest that both CRF and ACTH may be considered as putative mediators in the production of stress-induced anorexia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194823     DOI: 10.1016/0014-2999(90)90175-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs.

Authors:  Alexander V Mayorov; So-Yeop Han; Minying Cai; Matthew R Hammer; Dev Trivedi; Victor J Hruby
Journal:  Chem Biol Drug Des       Date:  2006-05       Impact factor: 2.817

2.  Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.

Authors:  Alexander V Mayorov; Minying Cai; Kevin B Chandler; Ravil R Petrov; April R Van Scoy; Zerui Yu; Dustin K Tanaka; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

3.  Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Zhihua Liu; James P Cain; Josef Vagner; Dev Trivedi; Victor J Hruby
Journal:  Peptides       Date:  2010-08-03       Impact factor: 3.750

Review 4.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

5.  The behavioral syndrome induced by adreno corticotropic hormone in rats is prevented by Ca++ channel blockade.

Authors:  R Poggioli; E Rasori; A Bertolini
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

6.  Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin Receptors.

Authors:  Minying Cai; Udaya Kiran Marelli; Jennifer Bao; Johannes G Beck; Florian Opperer; Florian Rechenmacher; Kaitlyn R McLeod; Morgan R Zingsheim; Lucas Doedens; Horst Kessler; Victor J Hruby
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

7.  Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor.

Authors:  Hongchang Qu; Minying Cai; Alexander V Mayorov; Paolo Grieco; Morgan Zingsheim; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

8.  Novel binding motif of ACTH analogues at the melanocortin receptors.

Authors:  Yingkui Yang; Victor J Hruby; Min Chen; Chiquito Crasto; Minying Cai; Carroll M Harmon
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

9.  Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Matthew M Dedek; James P Cain; April R Van Scoy; Bahar Tan; Josef Vagner; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2007-12-19       Impact factor: 7.446

Review 10.  Obesity, POMC, and POMC-processing Enzymes: Surprising Results From Animal Models.

Authors:  Iris Lindberg; Lloyd D Fricker
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 4.736

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.